54 results
8-K
EX-10.1
ORIC
ORIC Pharmaceuticals Inc
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
Documents, and the Company shall not amend or otherwise modify the Certificate of Incorporation or Bylaws prior to the Closing.
4.6 Litigation … of any litigation, if such settlement is effected with the written consent of the Company), insofar as such losses, claims, damages, liabilities
S-3
ORIC
ORIC Pharmaceuticals Inc
15 Dec 23
Shelf registration
4:32pm
litigation against our directors and officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder’s
8-K
EX-10.1
nm6ozd4o
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-99.2
xcce058mc59v6dr41xf
21 Dec 22
Other Events
5:25pm
424B5
5cg glqd753o
21 Dec 22
Prospectus supplement for primary offering
5:23pm
SC TO-I
EX-99
am1xyjkrt5loorxpf8
21 Jun 22
Issuer tender offer statement
4:06pm
SC TO-I
EX-99
a4b2phnirhcjcqmes71e
21 Jun 22
Issuer tender offer statement
4:06pm
POS AM
oam 6ci9rlb
22 Mar 22
Prospectus update (post-effective amendment)
4:07pm